Reply to Clarification- Financial results

anion December 24, 2025 To, To, Listing Department, The National Stock Exchange of India BSE Limited Ltd. Phiroze Jeejeebhoy Towers, The Listing Department Dalal Street, Exchange Plaza, Mumbai -— 400 001 Bandra — Kurla Complex, Ref: BSE Scrip Code: 544497 Mumbai -— 400051, NSE Scrip Code: AHCL Sub: Clarification on query raised by NSE through mail dated 23/12/2025 Respected Sir/Madam, With reference to the caption subject and with reference to your mail received through on December 23, 2025 for deficiency/ non submission observed in Financial Result for the quarter ended on June 30, 2025. Query Raised: 1. Machine Readable Form / Legible copy of Financial Results not submitted Our Reply: We have attached herewith Machine-Readable Form/ Legible copy of Financial Results for the quarter ended June 30, 2025. 2. Financial results submitted is not as per format prescribed by SEBI- Covering letter missing We have attached herewith covering letter with financial results for the quarter ended June 30, 2025. We hope our answer will satisfy your queries. Thanking You. For ANLON HEALTHCARE LIMITED PUNITKUMAR RASADIA MANAGING DIRECTOR DIN: 06696258 ANLON HEALTHCARE LIMITED CIN No.: U24230GJ2013PLC077543 REGISTERED OFFICE: 101/102, Silver Coin Complex, Opp. Crystal Mall, Kalawad Road, Rajkot-360005, Gujarat INDIA) PHONE NO.: +91-706969010/882 | Email: info@anlonhealthcare.com | www.anlon.in anion December 24, 2025 To, To, Listing Department, The National Stock Exchange of India BSE Limited Ltd. Phiroze Jeejeebhoy Towers, The Listing Department Dalal Street, Exchange Plaza, Mumbai -— 400 001 Bandra — Kurla Complex, Ref: BSE Scrip Code: 544497 Mumbai -— 400051, NSE Scrip Code: AHCL Sub: Financial Results for the quarter ended June 30, 2025. Respected Sir/Madam, Pursuant to Regulations 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose the unaudited standalone financial results of the Company for the quarter ended June 30, 2025, which have been approved and taken on record at a meeting of the Board of Directors of the Company held November 11, 2025. You are requested to take the above information on your record. Thanking You. For ANLON HEALTHCARE LIMITED PUNITKUMAR RASADIA MANAGING DIRECTOR DIN: 06696258 ANLON HEALTHCARE LIMITED CIN No.: U24230GJ2013PLC077543 REGISTERED OFFICE: 101/102, Silver Coin Complex, Opp. Crystal Mall, Kalawad Road, Rajkot- 360005, Gujarat (INDIA) PHONE NO.: +91-706969010/882 | Email: info@anlonhealthcare.com | www.anlon.in Independent Auditor's Review Report on the Quarterly and Year to date Unaudited Standalone Financial Results of the Company pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended Review Report to The Board of Directors Anlon Healthcare Limited (1) We have reviewed the accompanying statement of unaudited standalone financial results of Anlon Healthcare Limited (the 'Company’') for the quarter ended June 30, 2025 and year to date from April 01, 2025 to June 30, 2025 (the Statement’), attached herewith, being submitted by the Company pursuant to the requirement of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended (the ‘Listing Regulations’). (2) This Statement, which is the responsibility of the Company's Management and approved by the Company's Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34 (Ind AS 34), ‘Interim Financial Reporting’, prescribed under Section 133 of the Companies Act, 2013, as amended, read with relevant rules issued thereunder and other accounting principles generally accepted in India and in compliance with Regulation 33 of the Listing Regulations. Our responsibility is to express a conclusion on the Statement based on our review. (3) We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410, 'Review of Interim Financial Information Performed by the Independent Auditor of the Entity’ issued by the Institute of Chartered Accountants of India. This standard requires that we plan and perform the review to obtain moderate assurance as to whether the Statement is free of material misstatement. A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Standards on Auditing and consequently does not enable us to obtain assurance that we could become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion. (4) Based on our review conducted as above, nothing has come to our attention that causes us to believe that the accompanying Statement, prepared in accordance with the recognition and measurement principles laid down in the applicable Indian Accounting Standards (‘Ind AS') specified under Section 133 of the Companies Act, 2013, as amended, read with relevant rules issued thereunder and other accounting principles generally accepted in India, has not disclosed the information required to be disclosed in terms of Regulation 33 of the Listing Regulations, including the manner in which it is to be disclosed, or that it contains any material misstatement. For, RVD & Co Date: .l1../.1..2025 Place: Rajkot (Partner / , 3 M Ue Dm Ibe Nr :s 2h 5i p 17No 41 57 54 055 0 BMLN GY efa s RVD&Co Chartered Accountants . Level-06”,Office No 604-605,Near AP Park,Opp Imperial Heights, Rajkot-360005 Anlon Healthcare Limited CIN: U24230GJ2013PLC077543 Address: 101/102 - Silvercoin Complex, Opp. Crystal Mall, Kalawad Road, Rajkot, Gujarat, 360005 Standalone Balance Sheet as at 30-06-2025 Rs. in Lacs Quarter Ended Year Ended Particulars 30-06-2025 31 March 2025 Ghee verartice Audited ASSETS Non-current assets Property, Plant and Equipment 2,241.02 2,281.90 Total Non-current Assets 2,241.02 2,281.90 Current assets Inventories 5,159.28 5,026.31 Financial Assets Investments 91.91 90.91 Trade receivables 9,365.71 7,499.87 Cash and cash equivalents 185.67 144.96 Loans 224.84 227.95 Other financial assets 169.96 138.04 Other current assets 2,337.37 2,720.05 Total Current Assets 17,534.74 15,848.09 Total Assets 19,775.76 18,129.99 IL. EQUITY and LIABILITIES Equity Share Capital 3,935.15 3,985.15 Other Equity 4,411.71 4,057.02 Total Equity 8,396.86 8,042.17 Non-current liabilities Financial Liabilities Borrowings 3,841.49 3,835.70 Provisions 24.40 24.40 Deferred tax liabilities net 220.31 222.50 Total Non-current liabilities : 4,086.20 4,082.60 Current liabilities Financial Liabilities Borrowings 2,000.58 1,999.04 Trade Payables - total outstanding dues of micro enterprises and small enterprises 14.60 47.68 - total outstanding dues of others 3,378.91 1,916.67 Other current liabilities 878.40 1,178.05 Provisions - current 1,020.21 863.78 Total Current liabilities 7,292.70 6,005.22 Total liabilities 11,378.90 10,087.82 Total Equity and Liabilities 19,775.76 18,129.99 For and on behalf o f Boa rd of Directors, Anlon Healthcare Lim) Place: Rajkot { Date: November 11, 2025 itkumar R. Rasadia. °IGNED FOR JDENTIFICATIO; By Managing Director & RVD &Co. Chartered Accountants FRN 143936W Anion Healthcare Limited CIN: U24230GJ2013PLC077543 Address: 101/102 - Silvercoin Complex, Opp. Crystal Mall, Kalawad Road, Rajkot, Gujarat, 360005 Standalone Financial Result for the period ended on 30-06-2025 Rs. in Lacs Year Ended Sr No Particulars 30-06-2024 31 Marc h 2025 Un Audited Audited I Income Revenue From Operations 3,329.72 4,892.71 3,783.25 12,028.66 Other Income ay 4.23 6.09 16.85 Total Income (1) 3,330.89 4,896.94 3,789.34 12,045.51 II {Expenses Cost of materials consumed 2,959.48 - 2,790.25 1,949.10 7,128.82 Changes in inventorie [Showing first 8,000 characters — download PDF for full document]